Reversed Phase Columns Market Report 2026

Reversed Phase Columns Market Overview

• Reversed Phase Columns market size has reached to $1.56 billion in 2025 • Expected to grow to $2.35 billion in 2030 at a compound annual growth rate (CAGR) of 8.6% • Growth Driver: The Increasing Focus On Biologics Is Fueling Market Growth Due To Advancements In Biotechnology And Immunology • Market Trend: Innovations In Advanced Chromatography Column Technologies Enhancing Separation Efficiency And Biopharmaceutical Characterization • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Reversed Phase Columns Market?

Reversed phase columns refer to chromatography columns in which the stationary phase is non-polar (hydrophobic), while the mobile phase is relatively polar, allowing separation based on hydrophobic interactions. They are commonly used in liquid chromatography to separate compounds based on their polarity, with more non-polar substances retaining longer on the column. The main product types of reversed phase columns include octyl silica columns, butyl silica columns, phenyl columns, and cyano columns. Octyl silica columns refer to chromatographic columns used for separating moderately nonpolar compounds in analytical and laboratory applications. These columns are made using material types such as silica gel columns, polymer based columns, and composite columns. They are developed with particle technologies including fully porous particles, core shell superficially porous particles, and monolithic columns and they are used by end users including pharmaceutical and biotech companies, contract research organizations, academic and research institutes, food testing laboratories, environmental testing agencies, and hospitals and clinical labs.

What Is The Reversed Phase Columns Market Growth Forecast?

The reversed phase columns market size is expected to see strong growth in the next few years. It will grow to $2.35 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to growing biologics and biosimilar development, increasing demand for high throughput analytical workflows, rising focus on precision analytical testing, expansion of environmental and food safety testing requirements, increasing investment in advanced chromatography consumables. Major trends in the forecast period include increasing demand for high purity reversed phase columns, growing adoption of core shell particle technology for enhanced separation efficiency, rising use of reversed phase columns in pharmaceutical quality control testing, expansion of application specific chromatography columns for complex sample analysis, increasing development of high stability and long lifespan column materials.

Global Reversed Phase Columns Market Segmentation

1) By Product Type: Octyl Silica Columns, Butyl Silica Columns, Phenyl Columns, Cyano Columns 2) By Material Type: Silica Gel Columns, Polymer Based Columns, Composite Columns 3) By Particle Technology: Fully Porous Particles, Core Shell Superficially Porous Particles, Monolithic Columns 4) By End User: Pharmaceutical And Biotech Companies, Contract Research Organizations, Academic And Research Institutes, Food Testing Laboratories, Environmental Testing Agencies, Hospitals And Clinical Labs Subsegments: 1) By Octyl Silica Columns: Short Chain Octyl, Endcapped Octyl, Base Deactivated Octyl, High Purity Octyl 2) By Butyl Silica Columns: Short Chain Butyl, Endcapped Butyl, High Purity Butyl, Base Deactivated Butyl 3) By Phenyl Columns: Phenyl Hexyl, Biphenyl, Polar Embedded Phenyl, Standard Phenyl 4) By Cyano Columns: Fully Bonded Cyano, Polar Cyano, High Stability Cyano, Low Silanol Activity Cyano

What Is The Driver Of The Reversed Phase Columns Market?

The increasing focus on biologics is expected to propel the growth of the reversed phase columns market going forward. Biologics are therapeutic products derived from living organisms or their components that target specific pathways in the immune system to treat diseases. The emphasis on biologics is growing due to advancements in biotechnology and immunology, which have enabled the development of more precise and effective treatments that target the underlying mechanisms of immune-mediated conditions rather than merely managing symptoms. Reversed phase columns enable biologics analysis by delivering high-resolution separation and detailed characterization of complex biomolecules, thereby improving purity assessment, structural evaluation, and quality control across biopharmaceutical development and manufacturing. For instance, in February 2025, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, the 2023 WHO Essential Medicines List includes 81 biologic therapies, representing over 15% of all listed medicines. Therefore, the increasing focus on biologics is driving the growth of reversed phase columns industry.

Key Players In The Global Reversed Phase Columns Market

Major companies operating in the reversed phase columns market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Waters Corporation, Merck KGaA, Phenomenex Inc., Shimadzu Corporation, Tosoh Corporation, YMC Co. Ltd., Osaka Soda Co. Ltd., Daicel Corporation, Biotage AB, GL Sciences Inc., Restek Corporation, Hamilton Company, KNAUER Wissenschaftliche Geräte GmbH, SiliCycle Inc., Dikma Technologies Inc., Yamazen Corporation, Imtakt Corporation, Sepax Technologies Inc., Orochem Technologies Inc., MicroSolv Technology Corporation

Global Reversed Phase Columns Market Trends and Insights

Major companies operating in the reversed phase columns market are focusing on developing innovative solutions, such as novel chromatography columns, to enhance separation efficiency, improve resolution and selectivity, and enable faster, more accurate, and higher-throughput analytical workflows. Novel chromatography columns are advanced separation tools designed with improved stationary phases and technologies to deliver higher resolution, faster analysis, and better selectivity compared to traditional columns. For instance, in March 2024, Phenomenex, a US-based chromatography solutions provider, launched Biozen Native RP-1 and RP-5, an innovative reversed-phase column technology for advanced biopharmaceutical characterization. These columns are engineered with bioinert surfaces to minimize non-specific binding, improving peak shape and recovery of sensitive biomolecules such as monoclonal antibodies and ADCs. They utilize optimized stationary phase chemistries (RP-1 and RP-5 selectivities) to enable complementary separations, enhancing impurity profiling and structural characterization. The platform delivers high-throughput performance with improved efficiency and reproducibility compared to conventional reversed-phase columns, making it suitable for complex biologics, ADC payload analysis, and native-state protein separations.

What Are Latest Mergers And Acquisitions In The Reversed Phase Columns Market?

In December 2025, Römer Industries Holding GmbH, a Germany-based manufacturing company, acquired VDS optilab Chromatographietechnik GmbH for an undisclosed amount. With this acquisition, Römer Industries Holding GmbH aims to strengthen its presence in the analytical instrumentation and chromatography segment by expanding its product portfolio and enhancing its capabilities in high-precision separation technologies used in pharmaceutical and bioanalytical applications. VDS optilab Chromatographietechnik GmbH is a Germany-based company that provides a wide range of reversed-phase (RP) chromatography columns.

Regional Outlook

North America was the largest region in the reversed phase columns market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Reversed Phase Columns Market?

The reversed phase columns market consists of sales of polar-embedded reversed-phase columns, aqueous-compatible (AQ) columns, polymer-based reversed-phase columns, and monolithic silica columns. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Reversed Phase Columns Market Report 2026?

The reversed phase columns market research report is one of a series of new reports from The Business Research Company that provides reversed phase columns market statistics, including reversed phase columns industry global market size, regional shares, competitors with a reversed phase columns market share, detailed reversed phase columns market segments, market trends and opportunities, and any further data you may need to thrive in the reversed phase columns industry. This reversed phase columns market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.